Search

everythinglearnresearchcommunity

for

Search:↓

Increased blood vessel growth in lichen planopilaris may signal active disease needing aggressive treatment.

PLLA dermal fillers can cause hair loss, but it can be treated with steroids.

Lichen planopilaris can cause patchy hair loss in children and may respond to certain treatments.

LL-37 helps stem cells grow and move, aiding tissue regeneration and hair growth.

The review concluded that better studies are needed to prove if Low-Level Laser Therapy devices for hair growth really work.

A new variant of lichen planopilaris causing diffuse hair thinning was identified.

Patients with Lichen Planopilaris are more likely to have rosacea and skin cancer but less likely to have congestive heart failure, stroke, and glaucoma.

Lysophospholipids can act as anti-inflammatory agents through specific receptors, but more research is needed.

IVL-DrugFluidic® can mass-produce high-quality, long-acting injectable drug microspheres, improving patient compliance and reducing side effects.

Early diagnosis of leprosy is crucial to prevent disabilities and spread, even in non-endemic areas.

Lichen planopilaris in men often affects the scalp, eyebrows, arms, legs, and beard, with many having family members with hair loss.

P-SLN nanoparticles effectively deliver podophyllotoxin to the skin.

A specific mutation in PA-PLA1α causes abnormal hair growth.

Low-Level Laser Therapy might be a good alternative for hair loss when other treatments fail, but its effectiveness varies and more research is needed.

No treatment showed clear superiority for lichen planopilaris.

Low-level laser therapy effectively reduces the size of pressure ulcers compared to placebo.

The enzyme PA-PLA1α is important for proper hair follicle development.

Repaglinide-loaded liponiosomal hybrids improve blood sugar control and insulin release better than regular Repaglinide.

A woman has a permanent hair loss condition treated with steroids and new medicines, but hair might not regrow.

The improved nanoparticles can effectively target hair follicles for drug delivery.

Low level laser therapy is effective and safe for various skin and hair conditions.

Women in Australia report different signs of facial aging compared to women in the US, UK, and Canada; men with Lichen planopilaris often have hormonal abnormalities and thyroid disease.

Phospholipase A2 enzymes play key roles in skin health and disease.

Hair transplants can lead to hair loss from lichen planopilaris, and patients should be tested and wait two years before the procedure.

Platelet-rich plasma is tolerable for lichen planopilaris and doesn't worsen the condition, but its effectiveness is unclear.

The P&P Hairline Laser is a new, hands-free device that improves hairline symmetry in hair restoration surgery and can create a symmetrical hairline in less than a minute.

The woman was diagnosed with lichen planopilaris and can be treated with corticosteroids.

Managing frontal fibrosing alopecia and lichen planus pigmentosus is challenging due to resistant hair loss and skin discoloration.

Exosome treatment from stem cells improved hair regrowth and reduced scalp issues in a woman with lichen planopilaris.

Low-level light therapy is FDA-approved for male pattern hair loss, increases hair count and strength, and is considered safe for use.